Number of shares outstanding for ANI Pharmaceuticals (ANIP)

Number of shares outstanding as of December 2025 : 20,074,000

According to ANI Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 20,074,000. At the end of 2025 the company had 20,074,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for ANI Pharmaceuticals from 2013 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	20.07 M	3.23%
2024	19.44 M	2.98%
2023	18.88 M	15.67%
2022	16.32 M	15.22%
2021	14.16 M	18.11%
2020	11.99 M	0.93%
2019	11.88 M	1.33%
2018	11.73 M	1.53%
2017	11.55 M	0.77%
2016	11.46 M	0.37%
2015	11.42 M	1.2%
2014	11.28 M	18.74%
2013	9.5 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Jazz Pharmaceuticals JAZZ	60,696,000	202.36%	🇮🇪 Ireland
Evoke Pharma EVOK	2,553,174	-87.28%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	1,147,000,000	5,613.86%	🇮🇱 Israel
Pfizer PFE	5,685,000,000	28,220.22%	🇺🇸 USA
Lannett Company LCI	10,311,428	-48.63%	🇺🇸 USA
Celldex Therapeutics CLDX	66,420,000	230.88%	🇺🇸 USA
Cardinal Health CAH	238,000,000	1,085.61%	🇺🇸 USA
Novartis NVS	1,926,000,000	9,494.50%	🇨🇭 Switzerland
Royalty Pharma RPRX	429,027,000	2,037.23%	🇬🇧 UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions